Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10885755 | Drug Discovery Today | 2016 | 5 Pages |
Abstract
Billions of dollars spent, millions of subject-hours of clinical trial experience and an abundance of archived study-level data, yet why are historical data underutilized? We propose that historical data can be aggregated to provide safety, background incidence rate and context to improve the evaluation of new medicinal products. Here, we describe the development and application of the eControls database, which is derived from the control arms of studies of licensed products, and discuss the challenges and potential solutions to the proper application of historical data to help interpret product safety.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Prakash Bhuyan, Jigar Desai, Matthew St Louis, Martin Carlsson, Edward Bowen, Mark Danielson, Michael N. Cantor,